226 related articles for article (PubMed ID: 32171764)
1. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.
Núñez J; Bayés-Genís A; Revuelta-López E; Ter Maaten JM; Miñana G; Barallat J; Cserkóová A; Bodi V; Fernández-Cisnal A; Núñez E; Sanchis J; Lang C; Ng LL; Metra M; Voors AA
JACC Heart Fail; 2020 May; 8(5):386-397. PubMed ID: 32171764
[TBL] [Abstract][Full Text] [Related]
2. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure.
Núñez J; Bayés-Genís A; Revuelta-López E; Miñana G; Santas E; Ter Maaten JM; de la Espriella R; Carratalá A; Lorenzo M; Palau P; Llàcer P; Valle A; Bodi V; Núñez E; Lupón J; Lang C; Ng LL; Metra M; Sanchis J; Voors AA
Rev Esp Cardiol (Engl Ed); 2022 Apr; 75(4):316-324. PubMed ID: 33745912
[TBL] [Abstract][Full Text] [Related]
3. [Carbohydrate antigen 125 serial measurements after an admission for acute heart failure and risk of early readmission].
Miñana Escrivá G; Núñez J; Sanchis J; Bodi V; Núñez E; Chorro FJ; Llàcer A
Med Clin (Barc); 2012 Nov; 139(11):479-86. PubMed ID: 22093405
[TBL] [Abstract][Full Text] [Related]
4. Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.
Núñez J; Núñez E; Bayés-Genís A; Fonarow GC; Miñana G; Bodí V; Pascual-Figal D; Santas E; Garcia-Blas S; Chorro FJ; Rizopoulos D; Sanchis J
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):685-696. PubMed ID: 27199489
[TBL] [Abstract][Full Text] [Related]
5. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J; Llàcer P; Bertomeu-González V; Bosch MJ; Merlos P; García-Blas S; Montagud V; Bodí V; Bertomeu-Martínez V; Pedrosa V; Mendizábal A; Cordero A; Gallego J; Palau P; Miñana G; Santas E; Morell S; Llàcer A; Chorro FJ; Sanchis J; Fácila L;
JACC Heart Fail; 2016 Nov; 4(11):833-843. PubMed ID: 27522630
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of estimated plasma volume in acute heart failure in three cohort studies.
Kobayashi M; Rossignol P; Ferreira JP; Aragão I; Paku Y; Iwasaki Y; Watanabe M; Fudim M; Duarte K; Zannad F; Girerd N
Clin Res Cardiol; 2019 May; 108(5):549-561. PubMed ID: 30341579
[TBL] [Abstract][Full Text] [Related]
8. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Schmid H; Trenkwalder T; Mayr NP; Joner M; Kasel AM; Holdenrieder S; Nunez J; Sanchis J; Bodi V; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Am J Cardiol; 2018 Feb; 121(4):461-468. PubMed ID: 29306485
[TBL] [Abstract][Full Text] [Related]
10. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
Ng LL; Squire IB; Jones DJL; Cao TH; Chan DCS; Sandhu JK; Quinn PA; Davies JE; Struck J; Hartmann O; Bergmann A; Mebazaa A; Gayat E; Arrigo M; Akiyama E; Sabti Z; Lohrmann J; Twerenbold R; Herrmann T; Schumacher C; Kozhuharov N; Mueller C;
J Am Coll Cardiol; 2017 Jan; 69(1):56-69. PubMed ID: 28057251
[TBL] [Abstract][Full Text] [Related]
11. Mid-term prognostic impact of residual pulmonary congestion assessed by radiographic scoring in patients admitted for worsening heart failure.
Kobayashi M; Watanabe M; Coiro S; Bercker M; Paku Y; Iwasaki Y; Chikamori T; Yamashina A; Duarte K; Ferreira JP; Rossignol P; Zannad F; Girerd N
Int J Cardiol; 2019 Aug; 289():91-98. PubMed ID: 30770263
[TBL] [Abstract][Full Text] [Related]
12. Value of BNP and tumour marker CA125 in patients with heart failure.
Chen YX; Wang XQ; Fang CF; Wang JF; Tang LJ
Acta Cardiol; 2008 Aug; 63(4):501-6. PubMed ID: 18795589
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure.
Kouris NT; Kontogianni DD; Papoulia EP; Goranitou GS; Zaharos ID; Grassos HA; Kalkandi EM; Sifaki MD; Babalis DK
Hellenic J Cardiol; 2006; 47(5):269-74. PubMed ID: 17134062
[TBL] [Abstract][Full Text] [Related]
14. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure.
Ter Maaten JM; Kremer D; Demissei BG; Struck J; Bergmann A; Anker SD; Ng LL; Dickstein K; Metra M; Samani NJ; Romaine SPR; Cleland J; Girerd N; Lang CC; van Veldhuisen DJ; Voors AA
Eur J Heart Fail; 2019 Jun; 21(6):732-743. PubMed ID: 30843353
[TBL] [Abstract][Full Text] [Related]
15. Tumour biomarkers: association with heart failure outcomes.
Shi C; van der Wal HH; Silljé HHW; Dokter MM; van den Berg F; Huizinga L; Vriesema M; Post J; Anker SD; Cleland JG; Ng LL; Samani NJ; Dickstein K; Zannad F; Lang CC; van Haelst PL; Gietema JA; Metra M; Ameri P; Canepa M; van Veldhuisen DJ; Voors AA; de Boer RA
J Intern Med; 2020 Aug; 288(2):207-218. PubMed ID: 32372544
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.
Miñana G; de la Espriella R; Mollar A; Santas E; Núñez E; Valero E; Bodí V; Chorro FJ; Fernández-Cisnal A; Martí-Cervera J; Sanchis J; Bayés-Genís A; Núñez J
Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):437-447. PubMed ID: 32129669
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
[TBL] [Abstract][Full Text] [Related]
18. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J; Merlos P; Fácila L; Llàcer P; Bosch MJ; Bertomeu-Martínez V; García-Blas S; Montagud V; Pedrosa V; Mendizábal A; Cordero A; Miñana G; Sanchis J; Bertomeu-González V;
Rev Esp Cardiol (Engl Ed); 2015 Feb; 68(2):121-8. PubMed ID: 25623430
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.
Chen X; Wu M; Xu K; Huang M; Zhuo X
Acta Cardiol; 2021 Feb; 76(1):87-92. PubMed ID: 32519930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]